Life After 60
WhenIt's flexible! We'll work with your schedule.
Where740 Westwood PlazaLos Angeles, CA 90024
For those who are suffering from feelings of depression, sadness, hopelessness, memory loss, concentration difficulties, lack of energy, or loss of interest and pleasure in activities; UCLA is conducting a 12-week research study comparing levomilnacipran (FETZIMA) to placebo for treatment of geriatric depression. If you are 60 years of age or older, you may qualify. A complete psychiatric evaluation, physical exam, and one MRI scan are provided as a part of the study. All participants will be given either levomilnacipran (FETZIMA) or a placebo (an inactive substance). You will be compensated up to $200 and parking will be reimbursed.
Compensation is available! We offer $200 + parking
Study Site Contact Phone: (310) 267-5264
Study Site Contact Email: firstname.lastname@example.org
Good Match For
Requirements & Commitment